Clinical trial · Interventional
Efficacy of Ear Acupuncture in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Chemotherapy is a cancer therapy performed on advanced cancer with quite good success, but this therapy has quite a lot of side effects. Chemotherapy induced nausea and vomiting or commonly known as CINV, is a condition of nausea and vomiting experienced by cancer patients undergoing chemotherapy, with a prevalence of around 80% of all patients undergoing chemotherapy, and 40% has the potential to become severe. This study aims to determine the efficacy of a new acupuncture modality, namely the press needle, in preventing CINV symptoms in pediatric patients with cancer undergoing chemotherapy.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Chemotherapy Effect | — | UNRESOLVED | — |
| Chemotherapy-induced Nausea and Vomiting | — | UNRESOLVED | — |
| Pediatric Cancer | Childhood Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Plesterin | Device | — | UNRESOLVED |
| Press needle acupuncture | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- PLACEBO_COMPARATOR
- label
- Placebo
- description
- The control group was given a placebo press needle acupuncture (using plaster) with standard medical therapy for CINV prevention.
- interventionNames
- Device: Plesterin
- type
- EXPERIMENTAL
- label
- Acupuncture
- description
- The intervention group was given press needle acupuncture with standard medical therapy for CINV prevention.
- interventionNames
- Device: Press needle acupuncture
Primary outcomes (1)
- measure
- Rhodes Index of Nausea, Vomiting, and Retching (RINVR) questionnaire
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 6 Years
- Maximum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Pediatric patients with cancer who are undergoing chemotherapy. * Age 6 - 18 years. * Patients with platelet counts \> 20,000/μL and neutrophil values \> 1,000/μL. * Willing to follow the research. Exclusion Criteria: * Patients with local infection in the puncture area. * Patients with anatomic abnormalities in the auricle. * Did not complete the acupuncture therapy until it was finished (three days after chemotherapy).
References
Publications (0)
Data not yet available